Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination (Q61767322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

G Hardy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Burton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Pires

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Pido-Lopez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Moss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B Gazzard

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Gotch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

63-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

Decay characteristics of HIV-1-infected compartments during combination therapy

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Therapeutic vaccines in HIV.1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4-producing human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

A simple method for the measurement of sjTREC levels in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Rapid effector function in CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Human Immunodeficiency Virus Type 1 Infection of CD4+ T Cells Down-Regulates the Expression of CD28: Effect on T Cell Activation and Cytokine Production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Glucocorticoids in T cell development and function*.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

K21-antigen: a molecule shared by the microenvironments of the human thymus and germinal centers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2801%2900267-X

7 January 2021

10.1016/S0165-2478(01)00267-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11595291%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference